The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation
Open accessAbstract
Background: Transforming growth factor type beta 1 (TGF-β1) produces skeletal muscle atrophy. Angiotensin-(1-7) (Ang-(1-7)), through the Mas receptor, prevents the skeletal muscle atrophy induced by sepsis, immobilization, or angiotensin II (Ang-II). However, the effect of Ang-(1-7) on muscle wasting induced by TGF-β1 is unknown. Aim: To evaluate whether Ang-(1-7)/Mas receptor axis could prevent the skeletal muscle atrophy induced by TGF-β1. Methods: This study assessed the atrophic effect of TGF-β1 in C2C12 myotubes and mice in absence or presence of Ang-(1-7), and the receptor participation using A779, an antagonist of the Mas receptor. The levels of myosin heavy chain (MHC), polyubiquitination, and MuRF-1 were detected by western blot. Myotube diameter was also evaluated. In vivo analysis included the muscle strength, fibre diameter, MHC and MuRF-1 levels by western blot, and ROS levels by DCF probe detection. Results: The results showed that Ang-(1-7) prevented the increase in MuRF-1 and polyubiquitined protein levels, the decrease of MHC levels, the myotubes/fibre diameter diminution, and the increased production of reactive oxygen species (ROS) induced by TGF-β1. Utilizing A779 inhibited the anti-atrophic effect of Ang-(1-7). Conclusion: The preventive effect of Ang-(1-7) on skeletal muscle atrophy induced by TGF-β1 is produced through inhibition of ROS production and proteasomal degradation of MHC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding skeletal muscle, there is broad evidence about the antiatrophic and antisarcopenic role of Ang-(1-7) [141–144].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [143]
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Skeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Jiang, F., Zhang, Y., & Dusting, G. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002980 · Cited by 572
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold, L. I. (1999) · PubMed · Cited by 337
Transforming growth factor-β and myostatin signaling in skeletal muscle
Kollias, H. D., & McDermott, J. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01091.2007 · Cited by 307
Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy
Chen, Y. W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R., & Hoffman, E. P. (2005) · Neurology · doi:10.1212/01.wnl.0000173836.09176.c4 · Cited by 276
Brink, M., Wellen, J., & Delafontaine, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118698 · Cited by 262
Doyle, A., Zhang, G., Fattah, E. A. A., Eissa, N. T., & Li, Y. (2011) · The FASEB Journal · doi:10.1096/fj.10-164152 · Cited by 256
Iwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
Transforming growth factor β contributes to progressive diabetic nephropathy
Reeves, W. B., & Andreoli, T. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7667 · Cited by 225
Benter, I. F., Yousif, M. H. M., Dhaunsi, G. S., Kaur, J., Chappell, M. C., & Diz, D. I. (2008) · American Journal of Nephrology · doi:10.1159/000108758 · Cited by 204
Signaling mechanisms involved in disuse muscle atrophy
Zhang, P., Chen, X., & Fan, M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.11.043 · Cited by 203
Mendias, C. L., Gumucio, J. P., Davis, M. E., Bromley, C. W., Davis, C. S., & Brooks, S. V. (2012) · Muscle & Nerve · doi:10.1002/mus.22232 · Cited by 188
Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle
Cabello‐Verrugio, C., Morales, M. G., Rivera, J. C., Cabrera, D., & Simon, F. (2015) · Medicinal Research Reviews · doi:10.1002/med.21343 · Cited by 165
Self-citationSanders, P. M., Russell, S. T., & Tisdale, M. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602725 · Cited by 147
REGULATION OF SKELETAL MUSCLE PROTEIN TURNOVER DURING SEPSIS
Cooney, R. N., Kimball, S. R., & Vary, T. C. (1997) · Shock · doi:10.1097/00024382-199701000-00001 · Cited by 141
Mori, J., Patel, V. B., Ramprasath, T., Alrob, O. A., DesAulniers, J., Scholey, J. W., Lopaschuk, G. D., & Oudit, G. Y. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00655.2013 · Cited by 133
Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies
Bernasconi, P., Blasi, C. D., Mora, M., Morandi, L. O., Galbiati, S., Confalonieri, P. A., Cornelio, F., & Mantegazza, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00093-5 · Cited by 126
Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure
Libera, L. D., Zennaro, R., Sandri, M., Ambrosio, G. B., & Vescovo, G. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.5.c982 · Cited by 121
Cai, S., Yang, R., Li, Y., Ning, Z., Zhang, L., Zhou, G.-S., Luo, W., Li, D.-H., Chen, Y., Pan, M., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6498 · Cited by 111
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle
Henriksen, E. J., & Prasannarong, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.011 · Cited by 96
Russell, S. T., Eley, H. L., & Tisdale, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.003 · Cited by 92
Xiao, X., Zhang, C., Ma, X., Miao, H., Wang, J., Liu, L., Chen, S., Zeng, R., Chen, Y., & Bihl, J. C. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.06.010 · Cited by 89
Cabello‐Verrugio, C., Morales, M. G., Cabrera, D., Vio, C. P., & Brandan, E. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01354.x · Cited by 86
Self-citationLiang, B., Wang, X., Zhang, N., Yang, H., Bai, R., Liu, M., Bian, Y., Xiao, C., & Yang, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374047 · Cited by 86
Cisternas, F., Morales, M. G., Meneses, C., Simon, F., Brandan, E., Abrigo, J., Vazquez, Y., & Cabello-Verrugio, C. (2015) · Clinical Science · doi:10.1042/cs20140215 · Cited by 83
Self-citationMorales, M. G., Vázquez, Y., Acuña, M. J., Rivera, J. C. A., Simón, F., Salas, J. D., Álvarez‐Ruf, J., Brandan, E., & Cabello‐Verrugio, C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.028 · Cited by 81
Self-citationMechanism of induction of muscle protein degradation by angiotensin II
Russell, S. T., Wyke, S. M., & Tisdale, M. J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.09.009 · Cited by 79
Zhang, Y., Liu, J., Luo, J., Tian, X. Y., Cheang, W. S., Xu, J., Lau, C. W., Wang, L., Wong, W. T., Wong, C. M., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6070 · Cited by 77
Yousif, M. H. M., Dhaunsi, G. S., Makki, B., Qabazard, B. A., Akhtar, S., & Benter, I. F. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.001 · Cited by 71
Cabello‐Verrugio, C., Acuña, M. J., Morales, M. G., Becerra, Á., Simón, F., & Brandan, E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.051 · Cited by 69
Self-citationÁbrigo, J., Rivera, J. C. A., Simón, F., Cabrera, D., & Cabello‐Verrugio, C. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.010 · Cited by 68
Self-citationSarcomeric myosin heavy chain is degraded by the proteasome
Eble, D. M., Spragia, M. L., Ferguson, A. G., & Samarel, A. M. (1999) · Cell and Tissue Research · doi:10.1007/s004410051315 · Cited by 67
Marques, F. D., Melo, M. B., de Souza, L. E., Irigoyen, M. C., Sinisterra, R. D., Sousa, F. B. D., Savergnini, S. Q., Braga, V. B. A., Ferreira, A. J., & Santos, R. A. S. (2012) · International Journal of Hypertension · doi:10.1155/2012/795452 · Cited by 67
Meneses, C., Morales, M. G., Ábrigo, J., Simón, F., Brandan, E., & Cabello‐Verrugio, C. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1617-9 · Cited by 64
Self-citationAngiotensin II: Role in Skeletal Muscle Atrophy
Cabello‐Verrugio, C., Córdova, G., & Salas, J. D. (2012) · Current Protein and Peptide Science · doi:10.2174/138920312803582933 · Cited by 63
Self-citationElevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy
Ishitobi, M., Haginoya, K., Zhao, Y.-J., Ohnuma, A., Minato, J., Yanagisawa, T., Tanabu, M., Kikuchi, M., & Iinuma, K. (2000) · Neuroreport · doi:10.1097/00001756-200012180-00026 · Cited by 63
Morales, M. G., Olguín, H., Di Capua, G., Brandan, E., Simon, F., & Cabello-Verrugio, C. (2015) · Clinical Science · doi:10.1042/cs20140840 · Cited by 62
Self-citationAngiotensin‐(1–7) administration benefits cardiac, renal and progenitor cell function in db/db mice
Papinska, A., Mordwinkin, N. M., Meeks, C. J., Jadhav, S. S., & Rodgers, K. E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13225 · Cited by 57
Muscle Wasting in Cancer and Ageing: Cachexia Versus Sarcopenia
Argilés, J. M. A., Busquets, S., Orpí, M., Serpe, R., & López-Soriano, F. J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9713-2_2 · Cited by 57
Droguett, R., Cabello‐Verrugio, C., Santander, C., & Brandan, E. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.031 · Cited by 56
Self-citationResponsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle
Morris, R. T., Spangenburg, E. E., & Booth, F. W. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00454.2003 · Cited by 54
Morales, M. G., Ábrigo, J., Meneses, C., Simón, F., Cisternas, F., Rivera, J. C. A., Vázquez, Y., & Cabello‐Verrugio, C. (2014) · Clinical Science · doi:10.1042/cs20130585 · Cited by 51
Self-citationTGF-β signalopathies as a paradigm for translational medicine
Cannaerts, E., van de Beek, G., Verstraeten, A., Laer, L. V., & Loeys, B. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.10.010 · Cited by 48
Skeletal muscle studies in patients with HIV-related wasting syndrome
Miró, Ò., Pedrol, E., Cebrián, M., Masanés, F., Casademont, J., Mallolas, J., & Grau, J. M. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00079-8 · Cited by 42
Impaired Bone Homeostasis in Amyotrophic Lateral Sclerosis Mice with Muscle Atrophy
Zhu, K., Yi, J., Xiao, Y., Lai, Y., Song, P., Zheng, W., Jiao, H., Fan, J., Wu, C., Chen, D., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603985 · Cited by 41
Painemal, P., Acuña, M. J., Riquelme, C. A., Brandan, E., & Cabello‐Verrugio, C. (2013) · BioFactors · doi:10.1002/biof.1087 · Cited by 37
Self-citationAbrigo, J., Morales, M. G., Simon, F., Cabrera, D., Capua, G. D., & Cabello-Verrugio, C. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.06.011 · Cited by 20
Self-citationCofré, C., Acuña, M. J., Contreras, O., Morales, M. G., Riquelme, C. A., Cabello‐Verrugio, C., & Brandan, E. (2015) · BioFactors · doi:10.1002/biof.1208 · Cited by 10
Self-citation
Cited by
Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM
Kara, M., Kaymak, B., Frontera, W., Ata, A., Ricci, V, Ekiz, T., Chang, K., Han, D., Michail, X., Quittan, M., et al. (2021) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2851 · Cited by 183
“On the other hand, in the non-classical pathway, Ang (1–7) acts as an antagonist to Ang II and exerts an antifibrotic effect (55, 60).”
BackgroundMechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
“In contrast, angiotensin 1–7 produces beneficial effects in skeletal muscle by downregulating the catabolic pathway of sarcomere proteins and preventing the atrophic effects induced by TGF-β [194].”
BackgroundJiang, H., Chen, C., & Gao, J. (2022) · Nutrients · doi:10.3390/nu15010151 · Cited by 158
TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Wu, J., Lin, S., Chen, W., Lian, G., Wu, W., Chen, A., Sagor, M. I. H., Luo, L., Wang, H., & Xie, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01365-6 · Cited by 133
“Based on previous in vitro studies on sarcopenia [32], we then used MHC1 as a marker of the in vitro study of sarcopenia to explored whether TNF-α-induced sarcopenia is attributed to GSDME-mediated pyroptosis.”
MethodUbiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., & Taillandier, D. (2021) · Molecules · doi:10.3390/molecules26020407 · Cited by 95
Metadata
- Authors
- Ábrigo, J., Simon, F., Cabrera, D., & Cabello-Verrugio, C.
- Affiliations
- Universidad Andrés Bello (CL)
- Universidad Bernardo O'Higgins (CL)
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 40
- Issue
- 1-2
- Pages
- 27-38
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2555126138
- Cited by
- 35
- References
- 58
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 5 · 2020: 9 · 2019: 3 · 2018: 2 · 2017: 1
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Cellular Physiology and Biochemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repositorio Institucional Académico , Sistema de Bibliotecas Universidad Andrés Bello (UNAB) (Universidad Andrés Bello (UNAB)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- angiotensin-(1-7), Mas receptor, skeletal muscle atrophy, TGF-β1, MuRF1, myosin heavy chain, polyubiquitination, proteasomal degradation, reactive oxygen species, A779, C2C12 myotubes, muscle atrophy
- MeSH terms
- Tripartite Motif Proteins, Proto-Oncogene Mas, Angiotensin I, Animals, Cell Line, Mice, Inbred C57BL, Muscle Proteins, Muscular Atrophy, Myosins, Peptide Fragments, Proto-Oncogene Proteins, Transforming Growth Factor beta, Reactive Oxygen Species, Muscle, Skeletal, Muscle Fibers, Skeletal, Myosin Heavy Chains, Ubiquitin, Polyubiquitin, Receptors, G-Protein-Coupled, Ubiquitin-Protein Ligases, Proteasome Endopeptidase Complex, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.